Showing results (11-20 of 91) with videos related to
Sort By:
Pageof 10
Current Pharmaceutical Design|March 4, 2020
Epidemiology of Non-alcoholic Fatty Liver Disease in North AmericaTamoore Arshad, Pegah Golabi, Linda Henry, et al.Clinics in Liver Disease|July 11, 2017
Dermatologic Manifestations of Chronic Hepatitis C InfectionMehmet Sayiner, Pegah Golabi, Freba Farhat, et al.Hepatology International|November 9, 2019
Hepatocellular carcinoma and non-alcoholic fatty liver diseasePegah Golabi, Logan Rhea, Linda Henry, et al.Therapeutic Advances in Gastroenterology|November 28, 2018
Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitisMehmet Sayiner, Brian Lam, Pegah Golabi, et al.Medicine|October 19, 2018
Exercise as an intervention for patients with end-stage liver disease: Systematic reviewCameron T Locklear, Pegah Golabi, Lynn Gerber, et al.Clinics in Liver Disease|October 3, 2024
Alcohol and Metabolic Syndrome InteractionRyuki Hashida, Pegah Golabi, Janus Ong, et al.Hepatology Communications|January 9, 2019
Prevalence of Nonalcoholic Fatty Liver Disease in the Female PopulationTamoore Arshad, Pegah Golabi, James Paik, et al.Journal of Viral Hepatitis|July 12, 2019
Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis unitsRati Deshpande, Maria Stepanova, Pegah Golabi, et al.Clinics in Liver Disease|July 11, 2017
Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C InfectionPegah Golabi, Mehmet Sayiner, Haley Bush, et al.Hepatology (Baltimore, Md.)|February 12, 2020
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLDJames M Paik, Pegah Golabi, Youssef Younossi, et al.Pageof 10